MiNK THERAPEUTICS, INC. Convertible Promissory Note UP TO $5,000,000 February 12, 2024Convertible Note • March 21st, 2024 • MiNK Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 21st, 2024 Company Industry JurisdictionThis Convertible Promissory Note (this “Note”) is being issued by the Company pursuant to that certain Convertible Promissory Note Purchase Agreement, dated as of the date hereof, by and among the Company and the Holder (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.
AGENTUS THERAPEUTICS, INC. Convertible Promissory NoteConvertible Note • September 14th, 2021 • MiNK Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 14th, 2021 Company Industry JurisdictionThis Convertible Promissory Note (this “Note”) is being issued by the Company pursuant to that certain Convertible Promissory Note Purchase Agreement, dated as of the date hereof, by and among the Company and the Holder (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.